These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34265495)

  • 1. The role of MHC I protein dynamics in tapasin and TAPBPR-assisted immunopeptidome editing.
    van Hateren A; Elliott T
    Curr Opin Immunol; 2021 Jun; 70():138-143. PubMed ID: 34265495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAPBPR: a new player in the MHC class I presentation pathway.
    Hermann C; Trowsdale J; Boyle LH
    Tissue Antigens; 2015 Mar; 85(3):155-66. PubMed ID: 25720504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why TAPBPR? Implications of an additional player in MHC class I peptide presentation.
    Hafstrand I; Aflalo A; Boyle LH
    Curr Opin Immunol; 2021 Jun; 70():90-94. PubMed ID: 34052734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing.
    Morozov GI; Zhao H; Mage MG; Boyd LF; Jiang J; Dolan MA; Venna R; Norcross MA; McMurtrey CP; Hildebrand W; Schuck P; Natarajan K; Margulies DH
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):E1006-15. PubMed ID: 26869717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAPBPR mediates peptide dissociation from MHC class I using a leucine lever.
    Ilca FT; Neerincx A; Hermann C; Marcu A; Stevanović S; Deane JE; Boyle LH
    Elife; 2018 Nov; 7():. PubMed ID: 30484775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.
    Ilca FT; Neerincx A; Wills MR; de la Roche M; Boyle LH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9353-E9361. PubMed ID: 30213851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A loop structure allows TAPBPR to exert its dual function as MHC I chaperone and peptide editor.
    Sagert L; Hennig F; Thomas C; Tampé R
    Elife; 2020 Mar; 9():. PubMed ID: 32167472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst.
    Hermann C; van Hateren A; Trautwein N; Neerincx A; Duriez PJ; Stevanović S; Trowsdale J; Deane JE; Elliott T; Boyle LH
    Elife; 2015 Oct; 4():. PubMed ID: 26439010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reanalysis of Immunopeptidomics Datasets Provides Mechanistic Insight into TAPBPR-Mediated Peptide Editing on HLA-A, -B and -C Molecules.
    Altenburg AF; Morley JL; Bauer J; Walz JS; Boyle LH
    Wellcome Open Res; 2024; 9():113. PubMed ID: 38800518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway.
    Boyle LH; Hermann C; Boname JM; Porter KM; Patel PA; Burr ML; Duncan LM; Harbour ME; Rhodes DA; Skjødt K; Lehner PJ; Trowsdale J
    Proc Natl Acad Sci U S A; 2013 Feb; 110(9):3465-70. PubMed ID: 23401559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualising tapasin- and TAPBPR-assisted editing of major histocompatibility complex class-I immunopeptidomes.
    van Hateren A; Elliott T
    Curr Opin Immunol; 2023 Aug; 83():102340. PubMed ID: 37245412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway.
    Natarajan K; Jiang J; Margulies DH
    Crit Rev Biochem Mol Biol; 2019 Apr; 54(2):164-173. PubMed ID: 31084439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide exchange on MHC-I by TAPBPR is driven by a negative allostery release cycle.
    McShan AC; Natarajan K; Kumirov VK; Flores-Solis D; Jiang J; Badstübner M; Toor JS; Bagshaw CR; Kovrigin EL; Margulies DH; Sgourakis NG
    Nat Chem Biol; 2018 Aug; 14(8):811-820. PubMed ID: 29988068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAPBPR promotes antigen loading on MHC-I molecules using a peptide trap.
    McShan AC; Devlin CA; Morozov GI; Overall SA; Moschidi D; Akella N; Procko E; Sgourakis NG
    Nat Commun; 2021 May; 12(1):3174. PubMed ID: 34039964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and dynamic studies of TAPBPR and Tapasin reveal the mechanism of peptide loading of MHC-I molecules.
    Margulies DH; Jiang J; Natarajan K
    Curr Opin Immunol; 2020 Jun; 64():71-79. PubMed ID: 32402827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of chaperone interactions on MHC-I for folding and antigen repertoire selection.
    McShan AC; Devlin CA; Overall SA; Park J; Toor JS; Moschidi D; Flores-Solis D; Choi H; Tripathi S; Procko E; Sgourakis NG
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25602-25613. PubMed ID: 31796585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes.
    Sun Y; Papadaki GF; Devlin CA; Danon JN; Young MC; Winters TJ; Burslem GM; Procko E; Sgourakis NG
    Sci Adv; 2023 Feb; 9(8):eade7151. PubMed ID: 36827371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential interaction of MHC class I with TAPBPR in the absence of glycosylation.
    Neerincx A; Boyle LH
    Mol Immunol; 2019 Sep; 113():58-66. PubMed ID: 30077416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Polymorphisms in HLA Class I Molecules Govern Their Susceptibility to Peptide Editing by TAPBPR.
    Ilca FT; Drexhage LZ; Brewin G; Peacock S; Boyle LH
    Cell Rep; 2019 Nov; 29(6):1621-1632.e3. PubMed ID: 31693900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The binding of TAPBPR and Tapasin to MHC class I is mutually exclusive.
    Hermann C; Strittmatter LM; Deane JE; Boyle LH
    J Immunol; 2013 Dec; 191(11):5743-50. PubMed ID: 24163410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.